Long-term efficacy, safety and resistance analyses of entecavir (ETV) treatment in Japanese nucleoside-naive patients with chronic hepatitis B (CHB)

被引：0
|
作者：
Omata, M. [1 ]
Takaguchi, K. [2 ]
Fujioka, S. [3 ]
Hayashi, N. [4 ]
Shindo, M. [5 ]
Chayama, K. [6 ]
Ishikawa, H. [7 ]
Seriu, T. [8 ]
Kobashi, H. [9 ]
Yokosuka, O. [10 ]
机构：
[1] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan
[2] Kagawa Prefectural Cent Hosp, Dept Internal Med, Kagawa, Japan
[3] Okayama Saiseikai Gen Hosp, Dept Internal Med, Okayama, Japan
[4] Osaka Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Osaka, Japan
[5] Akashi Municipal Hosp, Dept Internal Med, Div Liver Dis, Akashi, Hyogo, Japan
[6] Hiroshima Univ, Grad Sch Biomed Sci, Dept Med & Mol Sci, Hiroshima, Japan
[7] Bristol Myers KK, Res & Dev, Tokyo, Japan
[8] Bristol Myers Squibb Co, Res & Dev, New York, NY 10154 USA
[9] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Okayama, Japan
[10] Chiba Univ, Grad Sch Med, Dept Med & Clin Oncol, Chiba, Japan
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2008年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A30 / A30
页数：1
相关论文
共 50 条
  • [1] Long term efficacy, safety and resistance analyses of entecavir (ETV) treatment in Japanese nucleoside-naive patients with chronic hepatitis B (CHB)
    Mochida, S.
    Takaguchi, K.
    Yokosuka, O.
    Fujioka, S.
    Hayashi, N.
    Shindo, M.
    Chayama, K.
    Toyota, J.
    Ishikawa, H.
    Seriu, T.
    Omata, O.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S262 - S262
  • [2] Long-term use of entecavir in nucleoside-naive Japanese patients with chronic hepatitis B infection
    Yokosuka, Osamu
    Takaguchi, Koichi
    Fujioka, Shinichi
    Shindo, Michiko
    Chayama, Kazuaki
    Kobashi, Haruhiko
    Hayashi, Norio
    Sato, Chifumi
    Kiyosawa, Kendo
    Tanikawa, Kyuichi
    Ishikawa, Hiroki
    Masaki, Nobuyuki
    Seriu, Taku
    Omata, Masao
    JOURNAL OF HEPATOLOGY, 2010, 52 (06) : 791 - 799
  • [3] Entecavir: a potent antiviral with minimal long-term resistance in nucleoside-naive chronic hepatitis B patients
    Cheng, Pin-Nan
    Chang, Ting-Tsung
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2008, 6 (05) : 569 - 579
  • [4] HISTOLOGIC ASSESSMENT OF LONG-TERM ENTECAVIR (ETV) TREATMENT IN CHRONIC HEPATITIS B (CHB) PATIENTS
    Katano, Yoshiaki
    Kumada, Hiromitsu
    Kobashi, Haruhiko
    Toyoto, Joji
    Yokosuka, Osamu
    Takaguchi, Koichi
    Kage, Masayoshi
    Moriyama, Mitsuhiko
    Imozeki, Furnio
    Ishikawa, Hiroki
    Seriu, Toku
    Omota, Masao
    HEPATOLOGY, 2008, 48 (04) : 703A - 704A
  • [5] Entecavir (ETV) is superior to lamivudine (LVD) for the treatment of chronic hepatitis B (CHB): results of a phase 3 Chinese study (ETV-023) in nucleoside-naive patients
    Yao, Guangbi
    Chen, Chengwei
    Lu, Weilun
    Ren, Hong
    Tan, Deming
    Wang, Yuming
    Xu, Daozheng
    Liu, Jessica
    Xu, Dong
    Macdonald, Laurie
    Jiang, Michael
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A126 - A126
  • [6] Entecavir is superior to lamivudine for the treatment of chronic hepatitis B (CHB): Results of a phase 3 Chinese study (ETV-023) in nucleoside-naive patients
    Yao, G.
    Chen, C.
    Lu, W.
    Ren, H.
    Tan, D.
    Wang, Y.
    Xu, D.
    Jiang, M.
    Liu, J.
    Xu, D.
    MacDonald, L.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S193 - S193
  • [7] Two cases of development of entecavir resistance during entecavir treatment for nucleoside-naive chronic hepatitis B
    Haruhiko Kobashi
    Shin-ichi Fujioka
    Mitsuhiko Kawaguchi
    Hiromitsu Kumada
    Osamu Yokosuka
    Norio Hayashi
    Kazuyuki Suzuki
    Takeshi Okanoue
    Michio Sata
    Hirohito Tsubouchi
    Chifumi Sato
    Kendo Kiyosawa
    Kyuichi Tanikawa
    Taku Seriu
    Hiroki Ishikawa
    Akinobu Takaki
    Yoshiaki Iwasaki
    Toshiya Osawa
    Toshiyuki Takaki
    Kosaku Sakaguchi
    Yasushi Shiratori
    Kazuhide Yamamoto
    Daniel J. Tenney
    Masao Omata
    Hepatology International, 2009, 3 : 403 - 410
  • [8] Two cases of development of entecavir resistance during entecavir treatment for nucleoside-naive chronic hepatitis B
    Kobashi, Haruhiko
    Fujioka, Shin-ichi
    Kawaguchi, Mitsuhiko
    Kumada, Hiromitsu
    Yokosuka, Osamu
    Hayashi, Norio
    Suzuki, Kazuyuki
    Okanoue, Takeshi
    Sata, Michio
    Tsubouchi, Hirohito
    Sato, Chifumi
    Kiyosawa, Kendo
    Tanikawa, Kyuichi
    Seriu, Taku
    Ishikawa, Hiroki
    Takaki, Akinobu
    Iwasaki, Yoshiaki
    Osawa, Toshiya
    Takaki, Toshiyuki
    Sakaguchi, Kosaku
    Shiratori, Yasushi
    Yamamoto, Kazuhide
    Tenney, Daniel J.
    Omata, Masao
    HEPATOLOGY INTERNATIONAL, 2009, 3 (02) : 403 - 410
  • [9] Efficacy and safety of entecavir in nucleoside-naive, chronic hepatitis B patients: Phase II clinical study in Japan
    Kobashi, Haruhiko
    Takaguchi, Kouichi
    Ikeda, Hiroshi
    Yokosuka, Osamu
    Moriyama, Mitsuhiko
    Imazeki, Fumio
    Kage, Masayoshi
    Seriu, Taku
    Omata, Masao
    Sakaguchi, Kousaku
    Shiratori, Yasushi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 (02) : 255 - 261
  • [10] Efficacy of entecavir monotherapy in nucleoside-naive patients with chronic hepatitis B in a tertiary clinic setting
    Davison, S. A.
    Dobbins, T. A.
    Segaert, N.
    Koorey, D. J.
    Shackel, N. A.
    Bye, W. A.
    Selby, W. S.
    McCaughan, G. W.
    Strasser, S. I.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A282 - A282
12345